DOI: 10.1055/s-00000068

Seminars in Interventional Radiology

References

Abou-Alfa GK, Meyer T, Cheng A-L. et al.
Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial.

J Clin Oncol 2018;
36 (04) 207

Download Bibliographical Data

Search in:
Access: